MindMed Promotes Jeanne Bonelle to Executive Vice President, Technical Operations

NEW YORK: Mind Medicine (MindMed), Inc. (NEO: MMED; OTCQB: MMEDF), the leading psychedelic pharmaceutical company, announced the promotion of pharmaceutical industry veteran Jeanne Bonelle to Executive Vice President of Technical Operations.

Ms. Bonelle is overseeing the company's drug quality, drug manufacturing and regulatory processes.

Co-Founder and Co-Chief Executive Officer, JR Rahn said, Any serious pursuit of psychedelic drug development requires a deep understanding of the quality, regulatory and production techniques to create current Good Manufacturing Practices (cGMP) drug products to undertake FDA clinical trials. Jeanne is a leader in this space, and this promotion acknowledges the key role that she plays within the MindMed management team.

Ms. Bonelle has significant pharmaceutical industry expertise in supervising the quality, and regulatory processes required to produce cGMP medicines. MindMed is actively scaling and developing manufacturing processes for cGMP 18-MC and cGMP LSD to be used in the company's clinical drug trials.
(PRN)

Like This Article?
MindMed Promotes Jeanne Bonelle to Executive Vice President, Technical Operations